Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients

Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients

Abstract Acute myeloid leukemia (AML) is a serious, life-threatening, and hardly curable hematological malignancy that affects the myeloid cell progenies and challenges patients of all ages but mostly occurs in adults. Although several therapies are available including chemotherapy, allogeneic hemat...

Full description

Bibliographic Details
Main Authors: Faroogh Marofi, Heshu Sulaiman Rahman, Zaid Mahdi Jaber Al-Obaidi, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Wanich Suksatan, Aleksei Evgenievich Dorofeev, Navid Shomali, Max Stanley Chartrand, Yashwant Pathak, Ali Hassanzadeh, Behzad Baradaran, Majid Ahmadi, Hossein Saeedi, Safa Tahmasebi, Mostafa Jarahian
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Stem Cell Research & Therapy
Subjects:
Acute myeloid leukemia
Adoptive cell therapy
Chimeric antigen receptor T cells
Hematological malignancy
Target antigen
Online Access:https://doi.org/10.1186/s13287-021-02420-8

Internet

https://doi.org/10.1186/s13287-021-02420-8

Similar Items